Format

Send to

Choose Destination
See comment in PubMed Commons below
Surg Oncol Clin N Am. 2004 Oct;13(4):621-38, ix.

Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.

Author information

  • 1Department of Radiation Oncology, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, USA. Ross_A_Abrams@Rush.edu

Abstract

In 1991 a multidisciplinary group consisting of surgeons, radiation oncologists, medical oncologists, pathologists, research nurses, and laboratory scientists was organized at the Johns Hopkins Hospital to accelerate progress in understanding the clinical and basic biology of pancreatic carcinoma and to develop research protocols aimed at improving clinical outcomes. This article discusses the studies, data, and conclusions generated to date, in some cases preliminarily, for the clinical trials and algorithms the Johns Hopkins team applied to the postoperative adjuvant management of periampullary pancreatic and nonpancreatic periampullary adenocarcinomas during the interval 1991 to 2003.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk